Contineum Therapeutics (CTNM) IPO deck
Ontineum Therapeutics is advancing precision small molecule therapies for neurology, inflammation, and immunology diseases with high unmet needs.
![](/content/images/size/w1304/2024/04/2024-04-02_02-03-46-2.png)
Ontineum Therapeutics is advancing precision small molecule therapies for neurology, inflammation, and immunology diseases with high unmet needs.